AstraZeneca India Unit Puts Off Delisting From Local Stock Exchanges
This article was originally published in PharmAsia News
Executive Summary
AstraZeneca Pharma India decided to reschedule its plan to remove itself from India stock exchanges on advice of advisers who wanted clarifications and explanations.